SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001213900-13-004518
Filing Date
2013-08-16
Accepted
2013-08-16 06:10:31
Documents
11
Period of Report
2013-06-30
Filing Date Changed
2013-08-16

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0613_caldera.htm 10-Q 1318365
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER f10q0613ex31i_caldera.htm EX-31.1 18450
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER f10q0613ex31ii_caldera.htm EX-31.2 19226
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER f10q0613ex32i_caldera.htm EX-32.1 6660
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER f10q0613ex32ii_caldera.htm EX-32.2 6388
  Complete submission text file 0001213900-13-004518.txt   11836448

Data Files

Seq Description Document Type Size
6 cpsc-20130630.xml EX-101.INS 1149721
7 cpsc-20130630.xsd EX-101.SCH 75287
8 cpsc-20130630_cal.xml EX-101.CAL 58599
9 cpsc-20130630_def.xml EX-101.DEF 235195
10 cpsc-20130630_lab.xml EX-101.LAB 564042
11 cpsc-20130630_pre.xml EX-101.PRE 406550
Mailing Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544
Business Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544 505-661-2420
Caldera Pharmaceuticals Inc (Filer) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54748 | Film No.: 131043786
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 1